|
53
|
129
|
4h92A |
Radiation damage study of lysozyme- 0.42 mgy |
|
53
|
129
|
4h9aA |
Radiation damage study of lysozyme - 0.63 mgy |
|
61
|
183
|
4hjyA |
2.4 a crystal structure of e. coli mlte-e64q with bound chitopentaose |
|
52
|
129
|
4h9eA |
Radiation damage study of lysozyme - 0.84 mgy |
|
53
|
129
|
4h93A |
Radiation damage study of lysozyme - 0.49 mgy |
|
67
|
183
|
4hjzA |
1.9 a crystal structure of e. coli mlte-e64q with bound chitopentaose |
|
53
|
129
|
4h94A |
Radiation damage in lysozyme - 0.56 mgy |
|
53
|
129
|
4h9iA |
Radiation damage study of lysozyme - 1.05 mgy |
|
53
|
129
|
4h9fA |
Radiation damage study of lysozyme - 0.91 mgy |
|
53
|
129
|
4h9hA |
Radiation damage study of lysozyme - 0.98 mgy |
|
44
|
128
|
4h1pA |
Use of europium for sad phasing at the cu k alpha wavelength |
|
154
|
461
|
4grvA |
The crystal structure of the neurotensin receptor nts1 in complex with neurotensin (8-13) |
|
44
|
129
|
4glaA |
Obody nl8 bound to hen egg-white lysozyme |
|
47
|
129
|
4gccA |
Room temperature x-ray diffraction study of a 6-fold molar excess of a cisplatin/carboplatin mixture binding to hewl, dataset 1 |
|
49
|
129
|
4g4bA |
Room temperature x-ray diffraction study of cisplatin binding to hewl in dmso media with nag after 7 months of crystal storage |
|
45
|
129
|
4g4hA |
100k x-ray diffraction study of carboplatin binding to hewl in dmso media after 13 months of crystal storage |
|
48
|
129
|
4gcfA |
Room temperature x-ray diffraction study of a 6-fold molar excess of a cisplatin/carboplatin mixture binding to hewl, dataset 4 |
|
48
|
129
|
4glvA |
Obody am3l09 bound to hen egg-white lysozyme |
|
47
|
129
|
4gcdA |
Room temperature x-ray diffraction study of a 6-fold molar excess of a cisplatin/carboplatin mixture binding to hewl, dataset 2 |
|
46
|
129
|
4gceA |
Room temperature x-ray diffraction study of a 6-fold molar excess of a cisplatin/carboplatin mixture binding to hewl, dataset 3 |
|
55
|
129
|
4gn4A |
Obody am2ep06 bound to hen egg-white lysozyme |
|
46
|
129
|
4gcbA |
100k x-ray diffraction study of a 6-fold molar excess of a cisplatin/carboplatin mixture binding to hewl |
|
51
|
129
|
4gn5C |
Obody am3l15 bound to hen egg-white lysozyme |
|
50
|
162
|
4gbrB |
N-terminal t4 lysozyme fusion facilitates crystallization of a g protein coupled receptor |
|
48
|
129
|
4g4cA |
Room temperature x-ray diffraction study of carboplatin binding to hewl in dmso media after 13 months of crystal storage |
|
46
|
129
|
4g49A |
Room temperature x-ray diffraction of cisplatin binding to hewl in aqueous media after 15 months of crystal storage |
|
48
|
129
|
4gn3A |
Obody am1l10 bound to hen egg-white lysozyme |
|
74
|
187
|
4g9sA |
Crystal structure of escherichia coli plig in complex with atlantic salmon g-type lysozyme |
|
45
|
129
|
3qy4A |
Crystallization and in situ data collection of lysozyme using the crystal former |
|
96
|
295
|
4fdyA |
Crystal structure of a similar to lipoprotein, nlp/p60 family (sav0400) from staphylococcus aureus subsp. aureus mu50 at 2.23 a resolution |
|
45
|
129
|
4fjrA |
Mode of interaction of merocyanine 540 with hew lysozyme |
|
167
|
453
|
3qakA |
Agonist bound structure of the human adenosine a2a receptor |
|
47
|
129
|
3qe8A |
Crystal structure analysis of lysozyme-bound fac-[re(co)3(h2o)(im)]+ |
|
163
|
432
|
3pblA |
Structure of the human dopamine d3 receptor in complex with eticlopride |
|
143
|
442
|
3pdsA |
Irreversible agonist-beta2 adrenoceptor complex |
|
43
|
129
|
3p64A |
Time-dependent and protein-directed in situ growth of gold nanoparticles in a single crystal of lysozyme |
|
161
|
466
|
3oduA |
The 2.5 a structure of the cxcr4 chemokine receptor in complex with small molecule antagonist it1t |
|
47
|
129
|
3p68A |
Time-dependent and protein-directed in situ growth of gold nanoparticles in a single crystal of lysozyme |
|
46
|
129
|
3ojpA |
D52n mutant of hen egg white lysozyme (hewl) |
|
168
|
440
|
3oe0A |
Crystal structure of the cxcr4 chemokine receptor in complex with a cyclic peptide antagonist cvx15 |
|
45
|
129
|
3p65A |
Time-dependent and protein-directed in situ growth of gold nanoparticles in a single crystal of lysozyme |
|
46
|
129
|
3ok0A |
E35a mutant of hen egg white lysozyme (hewl) |
|
45
|
129
|
3p4zA |
Time-dependent and protein-directed in situ growth of gold nanoparticles in a single crystal of lysozyme |
|
137
|
437
|
3oe9A |
Crystal structure of the chemokine cxcr4 receptor in complex with a small molecule antagonist it1t in p1 spacegroup |
|
43
|
129
|
3p66A |
Time-dependent and protein-directed in situ growth of gold nanoparticles in a single crystal of lysozyme |
|
166
|
439
|
3nyaA |
Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol |
|
133
|
442
|
3oe6A |
Crystal structure of the cxcr4 chemokine receptor in complex with a small molecule antagonist it1t in i222 spacegroup |
|
167
|
439
|
3ny8A |
Crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ici 118,551 |
|
162
|
439
|
3ny9A |
Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse agonist |
|
158
|
443
|
3oe8A |
Crystal structure of the cxcr4 chemokine receptor in complex with a small molecule antagonist it1t in p1 spacegroup |
